Sirolimus and lymphocele formation after kidney transplantation: An immunosuppressive medication as co-factor for a surgical problem? [4]

Nephrology Dialysis Transplantation

Volumn 18, Issue 2, 2003, Pages 448-449

  Giessing, Markus ^a   Budde, Klemens ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; FIBRINOGEN; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ABDOMINAL DISCOMFORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; FIBRINOGEN BLOOD LEVEL; HEPATITIS; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEG EDEMA; LETTER; LYMPHOCELE; NEPHRECTOMY; PATIENT MONITORING; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; SEPTIC SHOCK;

ADULT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCELE; MIDDLE AGED; POSTOPERATIVE PERIOD; SIROLIMUS;

EID: 0037312604     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.2.448     Document Type: Letter

References (5)

1. Chiu MI, Katz H, Berlin V. RAPT1, a mammalian homolog of yeast TOR, interacts with the FKBP12/rapamycin complex. Proc Natl Acad Sci USA 1994; 91: 12574-12578
2. Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renallograft rejection: a randomised multicentre study. Lancet 2000; 356: 194-202
3. Glass LL, Cockett ATK. Lymphoceles and management in urologic patients. Urology 1998; 51: 135-140
4. Khauli RB, Stoff JS, Lovewell T et al. Post-transplant lymphoceles: a critical look into the risk factors, pathophysiology and management. J Urol 1993; 150: 22-26
5. Bischof G, Rockenschaub S, Berlakovich G et al. Management of lymphoceles after kidney transplantation. Transpl Int 1998; 11: 277-280